Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions (Q40861503)

24 September 2017

1 reference

title

Antiendotoxin strategies for the prevention and treatment of septic shock. New approaches and future directions (English)

1 reference

24 September 2017

0 references

1 reference

Opal SM

1

1 reference

24 September 2017

Yu RL Jr

series ordinal

2

1 reference

24 September 2017

publication date

1 April 1998

1 reference

24 September 2017

1 reference

24 September 2017

volume

55

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

497-508

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199855040-00002

24 September 2017

exact match

0 references

cites work

Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.

1 reference

12 December 2020

Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein.

1 reference

12 December 2020

Identification of a lipopolysaccharide binding domain in CD14 between amino acids 57 and 64.

1 reference

12 December 2020

Bactericidal/permeability increasing protein and host defense against gram-negative bacteria and endotoxin

1 reference

12 December 2020

Endotoxin filtration and immune stimulation improve survival from gram-negative sepsis.

1 reference

12 December 2020

Recognition of endotoxin by cells leading to transmembrane signaling

1 reference

12 December 2020

Neutralization of the hemodynamic effects of endotoxin by polymyxin B.

1 reference

12 December 2020

Endotoxin-mediated endothelial cell injury and activation: role of soluble CD14.

1 reference

12 December 2020

Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice

1 reference

12 December 2020

The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin

1 reference

12 December 2020

Cytokine induction by lipopolysaccharide (LPS) corresponds to lethal toxicity and is inhibited by nontoxic Rhodobacter capsulatus LPS.

1 reference

12 December 2020

The Microspheres based Detoxification System (MDS). A new extracorporeal blood purification technology based on recirculated microspherical adsorbent particles

1 reference

12 December 2020

Transgenic mice expressing human CD14 are hypersensitive to lipopolysaccharide

1 reference

12 December 2020

Antibacterial agents that inhibit lipid A biosynthesis.

1 reference

12 December 2020

Antibiotic-induced release of endotoxin from bacteria in vitro.

1 reference

12 December 2020

Inhibition of endotoxin-induced activation of human monocytes by human lipoproteins

1 reference

12 December 2020

Repression of lipopolysaccharide biosynthesis in Escherichia coli by an antisense RNA of Acetobacter methanolicus phage Acm1.

1 reference

12 December 2020

E5531, a pure endotoxin antagonist of high potency

1 reference

12 December 2020

Potential hazards of combination immunotherapy in the treatment of experimental septic shock

1 reference

12 December 2020

Structural and functional organization of the human neutrophil 60 kDa bactericidal/permeability-increasing protein

1 reference

12 December 2020

Sequential anti-core glycolipid immunoglobulin antibody activities in patients with and without septic shock and their relation to outcome.

1 reference

12 December 2020

Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment

1 reference

12 December 2020

CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition

1 reference

12 December 2020

Immunoprophylaxis against klebsiella and pseudomonas aeruginosa infections. The Federal Hyperimmune Immunoglobulin Trial Study Group

1 reference

12 December 2020

Relative concentrations of endotoxin-binding proteins in body fluids during infection

1 reference

12 December 2020

Antiinflammatory effects of reconstituted high-density lipoprotein during human endotoxemia

1 reference

12 December 2020

The lipid A biosynthesis mutation lpxA2 of Escherichia coli results in drastic antibiotic supersusceptibility

1 reference

12 December 2020

Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein

1 reference

12 December 2020

The envA permeability/cell division gene of Escherichia coli encodes the second enzyme of lipid A biosynthesis. UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase

1 reference

12 December 2020

Endotoxins and disease mechanisms

1 reference

12 December 2020

Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group

1 reference

12 December 2020

Antibodies against CD14 protect primates from endotoxin-induced shock

1 reference

12 December 2020

A controlled trial of HA-1A in a canine model of gram-negative septic shock.

1 reference

12 December 2020

A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial. The E5 Sepsis Study Group

1 reference

12 December 2020

A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis Group B outer membrane protein produces protective antibodies against gram-negative bacteremia.

1 reference

12 December 2020

Endotoxin eliminating therapy in patients with severe sepsis--direct hemoperfusion using polymyxin B immobilized fiber column

1 reference

12 December 2020

Extracorporeal endotoxin removal in a canine model of septic shock

1 reference

12 December 2020

The firA gene of Escherichia coli encodes UDP-3-O-(R-3-hydroxymyristoyl)-glucosamine N-acyltransferase. The third step of endotoxin biosynthesis

1 reference

12 December 2020

Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity

1 reference

12 December 2020

Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.

1 reference

12 December 2020

Affinity-purified Escherichia coli J5 lipopolysaccharide-specific IgG protects neutropenic rats against gram-negative bacterial sepsis.

1 reference

12 December 2020

A new class of synthetic antibacterials acting on lipopolysaccharide biosynthesis

1 reference

12 December 2020

A mutant of Escherichia coli defective in the first step of endotoxin biosynthesis

1 reference

12 December 2020

CD14 is a pattern recognition receptor

1 reference

12 December 2020

Antibacterial agents specifically inhibiting lipopolysaccharide synthesis

1 reference

12 December 2020

Anti-endotoxin activity of a novel synthetic lipid A analog

1 reference

12 December 2020

In vivo protection against endotoxin by plasma high density lipoprotein

1 reference

12 December 2020

CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide

1 reference

12 December 2020

Bacterial endotoxins: extraordinary lipids that activate eucaryotic signal transduction

1 reference

12 December 2020

Identification of CD14 residues involved in specific lipopolysaccharide recognition

1 reference

12 December 2020

Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses

1 reference

12 December 2020

1 reference

12 December 2020

Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution

1 reference

12 December 2020

Competition between rBPI23, a recombinant fragment of bactericidal/permeability-increasing protein, and lipopolysaccharide (LPS)-binding protein for binding to LPS and gram-negative bacteria.

1 reference

12 December 2020

New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber

1 reference

12 December 2020

Lipopolysaccharide antagonists

1 reference

12 December 2020

Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immunological detoxification

1 reference

12 December 2020

CD14 and innate recognition of bacteria.

1 reference

12 December 2020

A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis. The XOMA Sepsis Study Group

1 reference

12 December 2020

Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4.

1 reference

12 December 2020

Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis

1 reference

12 December 2020

Production and characterization of a reconstituted high density lipoprotein for therapeutic applications

1 reference

12 December 2020

Association between protective efficacy of anti-lipopolysaccharide (LPS) antibodies and suppression of LPS-induced tumor necrosis factor alpha and interleukin 6. Comparison of O side chain-specific antibodies with core LPS antibodies

1 reference

12 December 2020

Antibody to Cell Wall Glycolipid of Gram-Negative Bacteria: Induction of Immunity to Bacteremia and Endotoxemia

1 reference

12 December 2020

Experimental study of extracorporeal perfusion for septic shock.

1 reference

12 December 2020

Immunotherapy of endotoxemia and septicemia

1 reference

12 December 2020

Natural cytokine antagonists and endogenous antiendotoxin core antibodies in sepsis syndrome. The Sepsis Intervention Group

1 reference

12 December 2020

Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin

1 reference

12 December 2020

Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber

1 reference

12 December 2020

Human antilipid A monoclonal antibodies bind to human B cells and the i antigen on cord red blood cells.

1 reference

12 December 2020

Bacterial endotoxin: molecular relationships of structure to activity and function

1 reference

12 December 2020

Treatment of gram-negative bacteremia and septic shock with HA-1A human monoclonal antibody against endotoxin. A randomized, double-blind, placebo-controlled trial. The HA-1A Sepsis Study Group

1 reference

12 December 2020

Assessment of ability of murine and human anti-lipid A monoclonal antibodies to bind and neutralize lipopolysaccharide

1 reference

12 December 2020

10.2165/00003495-199855040-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

24 September 2017

1022517475

0 references

1 reference